Company news

Bio-Techne Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Amendment to Annual Report (Form 10-K/A)

October 28, 2026

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

October 8, 2026

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

September 23, 2026

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

September 22, 2026

Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

September 1, 2026

Bio-Techne Corrects Dividend Announcement

August 13, 2026

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

August 12, 2026

Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio

July 8, 2026

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

June 25, 2026

Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

June 4, 2026

Bio-Techne Releases Third Quarter Fiscal 2026 Results

May 6, 2026

Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference

May 4, 2026

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

April 16, 2026

Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

April 13, 2026

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite

March 26, 2026

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

March 24, 2026

Evolve Announces March 2026 Distributions for UltraYield ETFs and Certain Evolve Funds

March 18, 2026

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

February 16, 2026

Bio-Techne Announces Changes to its Leadership Team

February 11, 2026

Bio-Techne Releases Second Quarter Fiscal 2026 Results

February 4, 2026

Bio-Techne Declares Dividend

February 4, 2026

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

February 2, 2026

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

January 28, 2026

Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results

January 19, 2026

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

December 22, 2025

Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology

December 10, 2025

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

December 8, 2025

Evolve Announces Estimated Annual Distributions for Certain Evolve Funds

December 2, 2025

Bio-Techne to Present at Upcoming Investor Conferences

November 24, 2025

Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

November 19, 2025

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

November 17, 2025

Bio-Techne Releases First Quarter Fiscal 2026 Results

November 4, 2025

Bio-Techne declares dividend

November 4, 2025

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

November 3, 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

November 3, 2025

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research

October 27, 2025

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital

October 23, 2025

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

October 14, 2025

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

October 8, 2025

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

September 25, 2025

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report

September 23, 2025

CONMED Corporation Adds Kim Kelderman to its Board of Directors

September 9, 2025

ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory

August 14, 2025

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

August 5, 2025

Bio-Techne Announces Exosome Diagnostics Divestiture

August 4, 2025

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering

July 31, 2025

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

July 16, 2025

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

July 14, 2025

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

July 13, 2025

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

June 23, 2025

Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.